HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects

Clinical and Experimental Hypertension

Volumn 30, Issue 5, 2008, Pages 297-307

  Esteghamati, Alireza ^a   Khalilzadeh, Omid ^b   Abbasi, Mehrshad ^a   Nakhjavani, Manouchehr ^a   Novin, Leila ^a   Esteghamati, Abdul Reza ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Homeostasis model assessment of insulin resistance; Hypertension; Insulin resistance; Type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GENERAL HOSPITAL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRAN; MAJOR CLINICAL STUDY; MALE; MODEL; PANCREAS ISLET BETA CELL; PATIENT REFERRAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; WAIST CIRCUMFERENCE;

ADULT; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; C-PEPTIDE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS;

EID: 47549095677     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802269919     Document Type: Article

References (43)

1. Lamounier-Zepter V, Ehrhart-Bornstein M, Bornstein SR. Insulin resistance in hypertension and cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2006;20:355-367.
2. Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 2003;88:2399-2403.
3. Landsberg L. Insulin resistance and hypertension. Clin Exp Hypertens 1999;21:885-894.
4. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: The Bruneck study. Diabetes Care 2007;30:318-324.
5. Fujiwara T, Saitoh S, Takagi S, Takeuchi H, Isobe T, Chiba Y, Miura T, Shimamoto K. Development and progression of atherosclerotic disease in relation to insulin resistance and hyperinsulinemia. Hypertens Res 2005;28:665-670.
6. Goff DC Jr, Zaccaro DJ, Haffner SM, Saad MF. Insulin sensitivity and the risk of incident hypertension: Insights from the Insulin Resistance Atherosclerosis Study. Diabetes Care 2003;26:805-809.
7. Dogru T, Sonmez A, Tasci I, Yilmaz MI, Kilic S, Ozgurtas T, Eyileten T, Erbil MK, Kocar IH. Plasma adiponectin and insulin resistance in new onset hypertension. Endocrine 2006;29:405-408.
8. Cabezas-Cerrato J, Garcia-Estevez DA, Araujo-Vilar D. Lack of association between both insulin resistance and plasma insulin levels with blood pressure values in essential hypertension. Horm Metab Res 1997;29:561-565.
9. Hwu CM, Hsiao CF, Grove J, Hung YJ, Chuang LM, Chen YT, Curb JD, Chen YD, Rodriguez B, Ho LT. Surrogate estimates of insulin sensitivity in subjects with hypertension. J Hum Hypertens 2007;21:246-252.
10. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002;19:527-534.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
12. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495.
13. Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study. Diabetes Care 2002;25:1135-1141.
14. Saad MF, Rewers M, Selby J, Howard G, Jinagouda S, Fahmi S, Zaccaro D, Bergman RN, Savage PJ, Haffner SM. Insulin resistance and hypertension: The Insulin Resistance Atherosclerosis study. Hypertension 2004;43:1324-1331.
15. Osei K, Schuster DP. Effects of race and ethnicity on insulin sensitivity, blood pressure, and heart rate in three ethnic populations: Comparative studies in African-Americans, African immigrants (Ghanaians), and white Americans using ambulatory blood pressure monitoring. Am J Hypertens 1996;9:1157-1164.
16. Marks V. An improved glucose-oxidase method for determining blood, CSF and urine glucose levels. Clin Chim Acta 1959;4:395-400.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
18. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2006. Available from: http://www.idf.org/webdata/ docs/IDF_Meta_def_final.pdf. Accessed April 16, 2007.
19. Sathiyapriya V, Nandeesha H, Bobby Z, Pavithran P, Selvaraj N, Rattina Dasse N. Insulin resistance and enhanced protein glycation in men with prehypertension. Clin Chem Lab Med 2006;44:1457-1461.
20. Sung KC, Ryu SH. Insulin resistance, body mass index, waist circumference are independent risk factor for high blood pressure. Clin Exp Hypertens 2004;26:547-556.
21. Kanauchi M, Yamano S, Kanauchi K, Saito Y. Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-normal blood pressure. J Clin Endocrinol Metab 2003;88:3444-3446.
22. Hirose H, Saito I, Kawabe H, Saruta T. Insulin resistance and hypertension: Seven-year follow-up study in middle-aged Japanese men: The KEIO study. Hypertens Res 2003;26:795-800.
23. Liese AD, Mayer-Davis EJ, Chambless LE, Folsom AR, Sharrett AR, Brancati FL, Heiss G. Elevated fasting insulin predicts incident hypertension: The ARIC study. Atherosclerosis Risk in Communities Study Investigators. J Hypertens 1999;17:1169-1177.
24. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Jarvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: Role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997;30:1144-1149.
25. Toft I, Bonaa KH, Jenssen T. Insulin resistance in hypertension is associated with body fat rather than blood pressure. Hypertension 1998;32:115-122.
26. Player MS, Mainous AG III, Diaz VA, Everett CJ. Prehypertension and insulin resistance in a nationally representative adult population. J Clin Hypertens (Greenwich) 2007;9:424-429.
27. Takizawa H, Ura N, Saitoh S, Wang L, Higashiura K, Takagi S, Takada M, Togashi N, Nakano M, Hayashi Y, Shimamoto K. Gender difference in the relationships among hyperleptinemia, hyperinsulinemia, and hypertension. Clin Exp Hypertens 2001;23:357-368.
28. Kanauchi M, Kanauchi K, Inoue T, Kimura K, Saito Y. Surrogate markers of insulin resistance in assessing individuals with new categories "prehypertension" and "prediabetes." Clin Chem Lab Med 2007;45:35-39.
29. Bonora E, Targher G, Alberiche M, Formentini G, Calcaterra F, Lombardi S, Marini F, Poli M, Zenari L, Raffaelli A, Perbellini S, Zenere MB, Saggiani F, Bonadonna RC, Muggeo M. Predictors of insulin sensitivity in Type 2 diabetes mellitus. Diabet Med 2002;19:535-542.
30. Afsar B, Sezer S, Elsurer R, Ozdemir FN. Is HOMA index a predictor of nocturnal nondipping in hypertensives with newly diagnosed type 2 diabetes mellitus? Blood Press Monit 2007;12:133-139.
31. Watson KE, Peters Harmel AL, Matson G. Atherosclerosis in type 2 diabetes mellitus: The role of insulin resistance. J Cardiovasc Pharmacol Ther 2003;8:253-260.
32. Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension. Diabetes 1993;42:764-772.
33. Sarafidis PA, McFarlane SI, Bakris GL. Antihypertensive agents, insulin sensitivity, and new-onset diabetes. Curr Diab Rep 2007;7:191-199.
34. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48.
35. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Buzzigoli E, Ghione S, Turchi S, Lombardi M, Ferrannini E. Visceral fat in hypertension: Influence on insulin resistance and beta-cell function. Hypertension 2004;44:127-133.
36. Anderson PJ, Critchley JA, Chan JC, Cockram CS, Lee ZS, Thomas GN, Tomlinson B. Factor analysis of the metabolic syndrome: Obesity vs. insulin resistance as the central abnormality. Int J Obes Relat Metab Disord 2001;25:1782-1788.
37. Chuang SY, Chou P, Hsu PF, Cheng HM, Tsai ST, Lin IF, Chen CH. Presence and progression of abdominal obesity are predictors of future high blood pressure and hypertension. Am J Hypertens 2006;19:788-795.
38. Thomas GN, Critchley JA, Tomlinson B, Anderson PJ, Lee ZS, Chan JC. Obesity, independent of insulin resistance, is a major determinant of blood pressure in normoglycemic Hong Kong Chinese. Metabolism 2000;49:1523-1528.
39. Siani A, Cappuccio FP, Barba G, Trevisan M, Farinaro E, Lacone R, Russo O, Russo P, Mancini M, Strazzullo P. The relationship of waist circumference to blood pressure: The Olivetti Heart Study. Am J Hypertens 2002;15:780-786.
40. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991;324:733-739.
41. Amoah AG, Schuster DP, Gaillard T, Osei K. Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians. Diabetologia 2003;46:949-955.
42. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 1988;37:338-345.
43. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PM, Schneider AE, Hales CN, Yudkin JS. The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 1990;33:532-537.